Tilray Brands (TSX:TLRY) has recently introduced a new line of hemp-derived Delta-9 THC beverages that will be available in key markets across the United States. These new beverages are being launched through Tilray’s Tilray Alternative Beverages business unit, featuring 420 Fizz, Herb & Bloom, Fizzy Jane’s, and Happy Flower, each containing 5mg of hemp-derived Delta-9 THC per can. The rollout of these new beverages is set to begin in October, with additional beverages planned for shipment later this year.
The company has strategically focused on the hemp-derived beverage category in the U.S. market, aiming to provide consumers with familiar, convenient, and enjoyable options to relax and unwind. This move aligns with a consumer-centric model that caters to different occasions and various consumer audiences at different price points. With the growing popularity of hemp-derived delta-9 products in the market, Tilray has been expanding its beverage business, particularly after acquiring Truss Beverage from Molson Coors (TSX:TPX.A) earlier this year.
Tilray operates as a global cannabis and consumer packaged goods company, managing over 20 brands in more than 20 countries. Currently, Tilray stock (TSX:TLRY) is trading at C$2.31 per share, with a decrease of 26.52% since the beginning of the year but a growth of 4.32% over the past three months.
For more information and to engage in discussions about this cannabis stock, interested parties can visit the Tilray Brands Inc. Bullboard on Stockhouse’s stock forums and message boards. It is crucial to note that the content provided in this article is for informational purposes only and should not be construed as investment advice. For a full disclaimer, please refer to the provided link.
